Read more
2:09 PM · 17 April 2026

Market wrap: Peace rumours and disapointing earnings

  • In the afternoon session, European indices are posting moderate gains, staying within 1%. The DAX is currently leading, with futures up around 0.9%. At the other end of the spectrum is the CAC40, down more than 0.5%.
  • News
    • The German aviation lobby is said to have appealed to European authorities to release emergency jet-fuel reserves to address shortages.
      • Sources close to peace talks in Pakistan claim that an Iran–US agreement is “close.”
        • The European Commission has allocated EUR 180 million to build European “cloud” infrastructure.
  • Macroeconomic
    • The amount of  data is exceptionally limited during Friday’s session. The euro area trade balance rises to EUR 11.5 billion, returning close to its average after a seasonal decline in March.
  • Company news
    • Uber increases its stake in Delivery Hero; shares rise about 2%.
    • Hensoldt receives a positive investment recommendation; shares gain 1%.
    • Ericsson reports results: weak sales and profitability below market expectations are weighing on valuations; shares fall more than 6%.
    • Alstom withdraws its cash-flow forecasts/targets; the stock plunges about 30%.
    • Traton, Deutsche Bahn, Daimler, DAF, Iveco and Volvo have concluded court proceedings related to price-fixing between 1997 and 2011. The companies must pay a total of EUR 3.5 billion.
  • Commodities
    • A growing perception in the market that peace in Iran is becoming more realistic is allowing oil prices to test local lows.
      • Brent falls more than 7%, stopping around $90 per barrel.
      • WTI drops below $90, reaching $87 per barrel.
17 April 2026, 5:39 PM

Rallies in European airline valuations

17 April 2026, 5:34 PM

US OPEN: The Strait of Hormuz is fully open 💥Euphoria in the markets 🚀

17 April 2026, 5:29 PM

⬇️WTI Oil declines nearly 9%

17 April 2026, 4:56 PM

OIL dips below $90 first time in a month🛢️ 📉 Iran will hand uranium to the US❓

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.